GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Cash Flow from Investing

Aroa Biosurgery (ASX:ARX) Cash Flow from Investing : A$9.31 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the six months ended in Mar. 2024, Aroa Biosurgery spent A$1.27 Mil on purchasing property, plant, equipment. It gained A$0.00 Mil from selling property, plant, and equipment. It spent A$0.00 Mil on purchasing business. It gained A$0.00 Mil from selling business. It spent A$0.00 Mil on purchasing investments. It gained A$0.00 Mil from selling investments. It paid A$0.18Mil for net Intangibles purchase and sale. And it received A$8.96 Mil from other investing activities. In all, Aroa Biosurgery gained A$7.51 Mil on investment activities in financial market and operating subsidiaries for the six months ended in Mar. 2024.


Aroa Biosurgery Cash Flow from Investing Historical Data

The historical data trend for Aroa Biosurgery's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery Cash Flow from Investing Chart

Aroa Biosurgery Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Cash Flow from Investing
- -19.74 -32.41 6.79 9.31

Aroa Biosurgery Semi-Annual Data
Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Cash Flow from Investing Get a 7-Day Free Trial -30.39 8.37 -1.58 1.80 7.51

Aroa Biosurgery Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Aroa Biosurgery's Cash Flow from Investing for the fiscal year that ended in Mar. 2024 is calculated as:

Aroa Biosurgery's Cash Flow from Investing for the quarter that ended in Mar. 2024 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$9.31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aroa Biosurgery  (ASX:ARX) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Aroa Biosurgery's purchase of property, plant, equipment for the six months ended in Mar. 2024 was A$-1.27 Mil. It means Aroa Biosurgery spent A$1.27 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Aroa Biosurgery's sale of property, plant, equipment for the six months ended in Mar. 2024 was A$0.00 Mil. It means Aroa Biosurgery gained A$0.00 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Aroa Biosurgery's purchase of business for the six months ended in Mar. 2024 was A$0.00 Mil. It means Aroa Biosurgery spent A$0.00 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Aroa Biosurgery's sale of business for the six months ended in Mar. 2024 was A$0.00 Mil. It means Aroa Biosurgery gained A$0.00 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Aroa Biosurgery's purchase of investment for the six months ended in Mar. 2024 was A$0.00 Mil. It means Aroa Biosurgery spent {stock_data.stock.currency_symbol}}0.00 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Aroa Biosurgery's sale of investment for the six months ended in Mar. 2024 was A$0.00 Mil. It means Aroa Biosurgery gained A$0.00 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Aroa Biosurgery's net Intangibles purchase and sale for the six months ended in Mar. 2024 was A$-0.18 Mil. It means Aroa Biosurgery paid A$0.18 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Aroa Biosurgery's cash from discontinued investing activities for the six months ended in Mar. 2024 was 0.00 Mil. It means Aroa Biosurgery paid A$0.00 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Aroa Biosurgery's cash from other investing activities for the six months ended in Mar. 2024 was A$8.96 Mil. It means Aroa Biosurgery received A$8.96 Mil from other investing activities.


Aroa Biosurgery Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Aroa Biosurgery (ASX:ARX) Business Description

Traded in Other Exchanges
N/A
Address
64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022
Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines